Nicorandil-Pretreated Mesenchymal Stem Cell-Derived Exosomes Facilitate Cardiac Repair After Myocardial Infarction via Promoting Macrophage M2 Polarization by Targeting miR-125a-5p/TRAF6/IRF5 Signaling Pathway

References

• Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528.
   PubMed Web of Science ®Google Scholar
• Bergmark BA, Mathenge N, Merlini PA, et al. Acute coronary syndromes. Lancet. 2022;399(10332):1347–1358. doi:10.1016/S0140-6736(21)02391-6
   PubMed Web of Science ®Google Scholar
• Yap J, Irei J, Lozano-Gerona J, et al. Macrophages in cardiac remodelling after myocardial infarction. Nat Rev Cardiol. 2023;20(6):373–385. doi:10.1038/s41569-022-00823-5
   PubMed Web of Science ®Google Scholar
• Weissman D, Maack C. Mitochondrial function in macrophages controls cardiac repair after myocardial infarction. J Clin Invest. 2023;133(4). doi:10.1172/JCI167079
   PubMed Web of Science ®Google Scholar
• Frantz S, Nahrendorf M. Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res. 2014;102(2):240–248. doi:10.1093/cvr/cvu025
   PubMed Web of Science ®Google Scholar
• Niu XH, Liu R-H, Lv X, et al. Activating α7nAChR helps post-myocardial infarction healing by regulating macrophage polarization via the STAT3 signaling pathway. Inflamm Res. 2023;72(4):879–892. doi:10.1007/s00011-023-01714-2
   PubMed Web of Science ®Google Scholar
• Karantalis V, Hare JM. Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015;116(8):1413–1430. doi:10.1161/CIRCRESAHA.116.303614
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang L, Sun Z, et al. HIF-1α overexpression in mesenchymal stem cell-derived exosome-encapsulated arginine-glycine-aspartate (RGD) hydrogels boost therapeutic efficacy of cardiac repair after myocardial infarction. Mater Today Bio. 2021;12:100171. doi:10.1016/j.mtbio.2021.100171
   PubMedGoogle Scholar
• Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4(3):206–216. doi:10.1016/j.stem.2009.02.001
   PubMed Web of Science ®Google Scholar
• Tu C, Mezynski R, Wu JC. Improving the engraftment and integration of cell transplantation for cardiac regeneration. Cardiovasc Res. 2020;116(3):473–475. doi:10.1093/cvr/cvz237
   PubMed Web of Science ®Google Scholar
• Yan W, Guo Y, Tao L, et al. C1q/tumor necrosis factor-related protein-9 regulates the fate of implanted mesenchymal stem cells and mobilizes their protective effects against ischemic heart injury via multiple novel signaling pathways. Circulation. 2017;136(22):2162–2177. doi:10.1161/CIRCULATIONAHA.117.029557
   PubMed Web of Science ®Google Scholar
• Rani S, Ritter T. The exosome - a naturally secreted nanoparticle and its application to wound healing. Adv Mater. 2016;28(27):5542–5552. doi:10.1002/adma.201504009
   PubMed Web of Science ®Google Scholar
• Kalluri R. The biology and function of exosomes in cancer. J Clin Invest. 2016;126(4):1208–1215. doi:10.1172/JCI81135
   PubMed Web of Science ®Google Scholar
• Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226–1232. doi:10.1016/j.cell.2016.01.043
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu J, Ma J, et al. Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer. 2019;18(1):116. doi:10.1186/s12943-019-1041-z
   PubMed Web of Science ®Google Scholar
• Lin KC, Yip H-K, Shao P-L, et al. Combination of adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes for protecting kidney from acute ischemia-reperfusion injury. Int J Cardiol. 2016;216:173–185. doi:10.1016/j.ijcard.2016.04.061
   PubMed Web of Science ®Google Scholar
• Marbán E. The secret life of exosomes: what bees can teach us about next-generation therapeutics. J Am Coll Cardiol. 2018;71(2):193–200. doi:10.1016/j.jacc.2017.11.013
   PubMed Web of Science ®Google Scholar
• Huang P, Wang L, Li Q, et al. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2020;116(2):353–367. doi:10.1093/cvr/cvz139
   PubMed Web of Science ®Google Scholar
• Chien KR, Frisén J, Fritsche-Danielson R, et al. Regenerating the field of cardiovascular cell therapy. Nat Biotechnol. 2019;37(3):232–237. doi:10.1038/s41587-019-0042-1
   PubMed Web of Science ®Google Scholar
• Barile L, Moccetti T, Marbán E, et al. Roles of exosomes in cardioprotection. Eur Heart J. 2017;38(18):1372–1379. doi:10.1093/eurheartj/ehw304
   PubMed Web of Science ®Google Scholar
• Zhu J, Lu K, Zhang N, et al. Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way. Artif Cells Nanomed Biotechnol. 2018;46(8):1659–1670. doi:10.1080/21691401.2017.1388249
   PubMed Web of Science ®Google Scholar
• Gray WD, French KM, Ghosh-Choudhary S, et al. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ Res. 2015;116(2):255–263. doi:10.1161/CIRCRESAHA.116.304360
   PubMed Web of Science ®Google Scholar
• Lee FY, Lu H-I, Zhen -Y-Y, et al. Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension. Eur J Pharm Sci. 2013;50(3–4):372–384. doi:10.1016/j.ejps.2013.08.004
   PubMed Web of Science ®Google Scholar
• Lefer DJ, Lefer AM. Studies on the mechanism of the vasodilator action of nicorandil. Life Sci. 1988;42(19):1907–1914. doi:10.1016/0024-3205(88)90031-8
   PubMed Web of Science ®Google Scholar
• Horinaka S. Use of nicorandil in cardiovascular disease and its optimization. Drugs. 2011;71(9):1105–1119. doi:10.2165/11592300-000000000-00000
   PubMed Web of Science ®Google Scholar
• Ning Y, Huang P, Chen G, et al. Atorvastatin-pretreated mesenchymal stem cell-derived extracellular vesicles promote cardiac repair after myocardial infarction via shifting macrophage polarization by targeting microRNA-139-3p/Stat1 pathway. BMC Med. 2023;21(1):96. doi:10.1186/s12916-023-02778-x
   PubMed Web of Science ®Google Scholar
• Xiong Y, Tang R, Xu J, et al. Tongxinluo-pretreated mesenchymal stem cells facilitate cardiac repair via exosomal transfer of miR-146a-5p targeting IRAK1/NF-κB p65 pathway. Stem Cell Res Ther. 2022;13(1):289. doi:10.1186/s13287-022-02969-y
   PubMed Web of Science ®Google Scholar
• Qian H-Y, Yang Y-J, Huang J, et al. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts. Chin Med J. 2007;120(16):1416–1425. doi:10.1097/00029330-200708020-00008
   PubMed Web of Science ®Google Scholar
• Mohamed SS, Ahmed LA, Attia WA, et al. Nicorandil enhances the efficacy of mesenchymal stem cell therapy in isoproterenol-induced heart failure in rats. Biochem Pharmacol. 2015;98(3):403–411. doi:10.1016/j.bcp.2015.10.004
   PubMed Web of Science ®Google Scholar
• Yang YJ, Qian H-Y, Huang J, et al. Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. Eur Heart J. 2008;29(12):1578–1590. doi:10.1093/eurheartj/ehn167
   PubMed Web of Science ®Google Scholar
• ShamsEldeen AM, El-Aal SAA, Aboulhoda BE, et al. Combined systemic intake of K-ATP opener (Nicorandil) and mesenchymal stem cells preconditioned with nicorandil alleviates pancreatic insufficiency in a model of bilateral renal ischemia/reperfusion injury. Front Physiol. 2022;13:934597. doi:10.3389/fphys.2022.934597
   PubMed Web of Science ®Google Scholar
• Zhang F, Cui J, Lv BO, et al. Nicorandil protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis. Int J Mol Med. 2015;36(2):415–423. doi:10.3892/ijmm.2015.2229
   PubMed Web of Science ®Google Scholar
• de Couto G, Gallet R, Cambier L, et al. Exosomal MicroRNA transfer into macrophages mediates cellular postconditioning. Circulation. 2017;136(2):200–214. doi:10.1161/CIRCULATIONAHA.116.024590
   PubMed Web of Science ®Google Scholar
• Murray PJ, Allen J, Biswas S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14–20. doi:10.1016/j.immuni.2014.06.008
   PubMed Web of Science ®Google Scholar
• Tang R, Wang K, Xiong Y, Meng J, Yang Y. A fluorescence assay for evaluating the permeability of a cardiac microvascular endothelial barrier in a rat model of ischemia/reperfusion. J Vis Exp. 2021;172:e62746.
   Google Scholar
• Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science. 2013;339(6116):161–166. doi:10.1126/science.1230719
   PubMed Web of Science ®Google Scholar
• Steinhoff G, Nesteruk J, Wolfien M, et al. Stem cells and heart disease - Brake or accelerator? Adv Drug Deliv Rev. 2017;120:2–24. doi:10.1016/j.addr.2017.10.007
   PubMed Web of Science ®Google Scholar
• Golpanian S, Wolf A, Hatzistergos KE, et al. Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiol Rev. 2016;96(3):1127–1168. doi:10.1152/physrev.00019.2015
   PubMed Web of Science ®Google Scholar
• Guo Y, Yu Y, Hu S, et al. The therapeutic potential of mesenchymal stem cells for cardiovascular diseases. Cell Death Dis. 2020;11(5):349. doi:10.1038/s41419-020-2542-9
   PubMed Web of Science ®Google Scholar
• Xu J, Xiong -Y-Y, Li Q, et al. Optimization of timing and times for administration of atorvastatin-pretreated mesenchymal stem cells in a preclinical model of acute myocardial infarction. Stem Cells Transl Med. 2019;8(10):1068–1083. doi:10.1002/sctm.19-0013
   PubMed Web of Science ®Google Scholar
• Arslan F, de Kleijn DP, Pasterkamp G. Innate immune signaling in cardiac ischemia. Nat Rev Cardiol. 2011;8(5):292–300. doi:10.1038/nrcardio.2011.38
   PubMed Web of Science ®Google Scholar
• Ghigo A, Franco I, Morello F, et al. Myocyte signalling in leucocyte recruitment to the heart. Cardiovasc Res. 2014;102(2):270–280. doi:10.1093/cvr/cvu030
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. The mechanistic basis of infarct healing. Antioxid Redox Signal. 2006;8(11–12):1907–1939. doi:10.1089/ars.2006.8.1907
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG, Rosenzweig A. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012;110(1):159–173. doi:10.1161/CIRCRESAHA.111.243162
   PubMed Web of Science ®Google Scholar
• Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119(1):91–112. doi:10.1161/CIRCRESAHA.116.303577
   PubMed Web of Science ®Google Scholar
• Liehn EA, Postea O, Curaj A, et al. Repair after myocardial infarction, between fantasy and reality: the role of chemokines. J Am Coll Cardiol. 2011;58(23):2357–2362. doi:10.1016/j.jacc.2011.08.034
   PubMed Web of Science ®Google Scholar
• Wen H, Peng L, Chen Y. The effect of immune cell-derived exosomes in the cardiac tissue repair after myocardial infarction: molecular mechanisms and pre-clinical evidence. J Cell Mol Med. 2021;25(14):6500–6510. doi:10.1111/jcmm.16686
   PubMed Web of Science ®Google Scholar
• Minami E, Castellani C, Malchodi L, et al. The role of macrophage-derived urokinase plasminogen activator in myocardial infarct repair: urokinase attenuates ventricular remodeling. J Mol Cell Cardiol. 2010;49(3):516–524. doi:10.1016/j.yjmcc.2010.03.022
   PubMed Web of Science ®Google Scholar
• Aurora AB, Porrello ER, Tan W, et al. Macrophages are required for neonatal heart regeneration. J Clin Invest. 2014;124(3):1382–1392. doi:10.1172/JCI72181
   PubMed Web of Science ®Google Scholar
• Ma Y, Mouton AJ, Lindsey ML. Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Transl Res. 2018;191:15–28. doi:10.1016/j.trsl.2017.10.001
   PubMed Web of Science ®Google Scholar
• Liu M, Yin L, Li W, et al. C1q/TNF-related protein-9 promotes macrophage polarization and improves cardiac dysfunction after myocardial infarction. J Cell Physiol. 2019;234(10):18731–18747. doi:10.1002/jcp.28513
   PubMed Web of Science ®Google Scholar
• Weirather J, Hofmann UDW, Beyersdorf N, et al. Foxp3 + CD4 + T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ Res. 2014;115(1):55–67. doi:10.1161/CIRCRESAHA.115.303895
   PubMed Web of Science ®Google Scholar
• Courties G, Heidt T, Sebas M, et al. In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. J Am Coll Cardiol. 2014;63(15):1556–1566. doi:10.1016/j.jacc.2013.11.023
   PubMed Web of Science ®Google Scholar
• Zhao J, Li X, Hu J, et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res. 2019;115(7):1205–1216. doi:10.1093/cvr/cvz040
   PubMed Web of Science ®Google Scholar
• Wang Y, Tan J, Wang L, et al. MiR-125 family in cardiovascular and cerebrovascular diseases. Front Cell Dev Biol. 2021;9:799049. doi:10.3389/fcell.2021.799049
   PubMed Web of Science ®Google Scholar
• Banerjee S, Cui H, Xie N, et al. miR-125a-5p regulates differential activation of macrophages and inflammation. J Biol Chem. 2013;288(49):35428–35436. doi:10.1074/jbc.M112.426866
   PubMed Web of Science ®Google Scholar
• Gao L, Qiu F, Cao H, et al. Therapeutic delivery of microRNA-125a-5p oligonucleotides improves recovery from myocardial ischemia/reperfusion injury in mice and swine. Theranostics. 2023;13(2):685–703. doi:10.7150/thno.73568
   PubMed Web of Science ®Google Scholar
• Galluzzo A, Gallo S, Pardini B, et al. Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing. ESC Heart Failure. 2021;8(4):2907–2919. doi:10.1002/ehf2.13371
   PubMed Web of Science ®Google Scholar
• Skaug B, Jiang X, Chen ZJ. The role of ubiquitin in NF-kappaB regulatory pathways. Annu Rev Biochem. 2009;78(1):769–796. doi:10.1146/annurev.biochem.78.070907.102750
   PubMedGoogle Scholar
• Ock S, Ahn J, Lee SH, et al. Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation. Cardiovasc Res. 2012;94(1):105–114. doi:10.1093/cvr/cvs078
   PubMed Web of Science ®Google Scholar
• Wang X, Ha T, Liu L, et al. Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. Cardiovasc Res. 2013;97(3):432–442. doi:10.1093/cvr/cvs356
   PubMed Web of Science ®Google Scholar
• Wang X, Ha T, Zou J, et al. MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6. Cardiovasc Res. 2014;102(3):385–395. doi:10.1093/cvr/cvu044
   PubMed Web of Science ®Google Scholar
• Walsh MC, Lee J, Choi Y. Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol Rev. 2015;266(1):72–92. doi:10.1111/imr.12302
   PubMed Web of Science ®Google Scholar
• Zhang Y, Le X, Zheng S, et al. MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization. Stem Cell Res Ther. 2022;13(1):171. doi:10.1186/s13287-022-02855-7
   PubMed Web of Science ®Google Scholar
• Sun J, Liao Z, Li Z, et al. Down-regulation miR-146a-5p in Schwann cell-derived exosomes induced macrophage M1 polarization by impairing the inhibition on TRAF6/NF-κB pathway after peripheral nerve injury. Exp Neurol. 2023;362:114295. doi:10.1016/j.expneurol.2022.114295
   PubMed Web of Science ®Google Scholar
• Wu W, Hu Y, Li J, et al. Silencing of Pellino1 improves post-infarct cardiac dysfunction and attenuates left ventricular remodelling in mice. Cardiovasc Res. 2014;102(1):46–55. doi:10.1093/cvr/cvu007
   PubMed Web of Science ®Google Scholar
• Krausgruber T, Blazek K, Smallie T, et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol. 2011;12(3):231–238. doi:10.1038/ni.1990
   PubMed Web of Science ®Google Scholar
• Crea F. New therapeutic targets to reduce inflammation-associated cardiovascular risk: the CCL2-CCR2 axis, LOX-1, and IRF5. Eur Heart J. 2022;43(19):1777–1781. doi:10.1093/eurheartj/ehac233
   PubMed Web of Science ®Google Scholar
• Saliba DG, Heger A, Eames H, et al. IRF5:RelA interaction targets inflammatory genes in macrophages. Cell Rep. 2014;8(5):1308–1317. doi:10.1016/j.celrep.2014.07.034
   PubMed Web of Science ®Google Scholar
• Edsfeldt A, Swart M, Singh P, et al. Interferon regulatory factor-5-dependent CD11c+ macrophages contribute to the formation of rupture-prone atherosclerotic plaques. Eur Heart J. 2022;43(19):1864–1877. doi:10.1093/eurheartj/ehab920
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu Z, Zhou H, et al. Increased sympathetic outflow induced by emotional stress aggravates myocardial ischemia-reperfusion injury via activation of TLR7/MyD88/IRF5 signaling pathway. Inflamm Res. 2023;72(5):901–913.
   PubMed Web of Science ®Google Scholar
• Chen H, Hou Y, Zhai Y, et al. Peli1 deletion in macrophages attenuates myocardial ischemia/reperfusion injury by suppressing M1 polarization. J Leukoc Biol. 2023;113(2):95–108. doi:10.1093/jleuko/qiac012
   PubMed Web of Science ®Google Scholar